Viewing Study NCT00065260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-02-07 @ 12:14 PM
Study NCT ID: NCT00065260
Status: COMPLETED
Last Update Posted: 2021-07-21
First Post: 2003-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alemtuzumab (Campath-1H) View
None Rabbit ATG View
None Severe Aplastic Anemia View
None Cyclosporine View
None Thrombocytopenia View
None Leukopenia View
None Neutropenia View
None Autoimmunity View
None Relapse View
None Anemia View